ERCC2, KDM6A, and TERT as Key Prognostic Factors in Bladder Cancer: Insights from the AACR Project GENIE DatabaseSeptember 8, 2025CancerOncologyConference CoverageGenitourinary Cancer
Papillary Cystadenocarcinoma: NCDB Insights on Outcomes and Socioeconomic DisparitiesSeptember 5, 2025OncologyGenitourinary CancerConference Coverage
Next-Gen Sequencing Tumor Testing Remains Low in Prostate and Urothelial Cancer CasesFebruary 21, 2025Genitourinary CancerOncology
Service Connection Expanded to Additional CancersJanuary 31, 2025Prostate CancerMultiple MyelomaGenitourinary Cancer
VA Study Asks: Has Active Surveillance Solved the Problem of Overtreatment? January 28, 2025Prostate CancerOncologyGenitourinary Cancer
Agent Orange and Uranium Exposures Associated With Bladder Cancer Risk in VeteransJanuary 16, 2025Genitourinary CancerOncology
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?December 6, 2024Immuno-oncologyMixed TopicsOncologyGenitourinary CancerMelanomaLung CancerVaccines
One-Dose HPV Vaccine Program Would Be Efficient in CanadaOctober 15, 2024VaccinesInfectious DiseasesSexual HealthOncologyGenitourinary Cancer
Transgender Women and Prostate Cancer: It’s ComplicatedSeptember 23, 2024Prostate CancerGenitourinary CancerOncologySexual Health
Few Severe Toxicities After SBRT in Oligometastatic CancerAugust 20, 2024Breast CancerLung CancerGenitourinary CancerOncologyColon and Rectal
Can Addressing Depression Reduce Chemo Toxicity in Older Adults?August 8, 2024Breast CancerGenitourinary CancerLung CancerMelanomaMixed TopicsOncologyGeriatrics
Genetics and Lifestyle Choices Can Affect Early Prostate Cancer DeathsJuly 11, 2024Genitourinary CancerOncology
In Prostate Cancer, Most Roads Lead to VA PathwayJuly 9, 2024Prostate CancerGenitourinary CancerOncology
